Charlotte Hulme c.hulme1@keele.ac.uk
The Developing Landscape of Diagnostic and Prognostic Biomarkers for Spinal Cord Injury in Cerebrospinal Fluid and Blood
Hulme, CH; Brown, SJ; Fuller, HR; Riddell, J; Osman, A; Chowdhury, J; Kumar, N; Johnson, WE; Wright, KT
Authors
Sharon Owen s.j.owen@keele.ac.uk
Heidi Fuller h.r.fuller@keele.ac.uk
J Riddell
A Osman
J Chowdhury
N Kumar
WE Johnson
Karina Wright k.t.wright@keele.ac.uk
Abstract
Objectives:
The identification of prognostic biomarkers of spinal cord injury (SCI) will help to assign SCI patients to the correct treatment and rehabilitation regimes. Further, the detection of biomarkers that predict permanent neurological outcome would aid in appropriate recruitment of patients into clinical trials. The objective of this review is to evaluate the current state-of-play in this developing field.
Setting:
Studies from multiple countries were included.
Methods:
We have completed a comprehensive review of studies that have investigated prognostic biomarkers in either the blood or cerebrospinal fluid (CSF) of animals and humans following SCI.
Results:
Targeted and unbiased approaches have identified several prognostic biomarkers in CSF and blood. These proteins associate with cellular damage following SCI and include components from neurons, oligodendrocytes and reactive astrocytes, that is, neurofilament proteins, glial fibrillary acidic protein, Tau and S100 calcium-binding protein ß. Unbiased approaches have also identified microRNAs that are specific to SCI, as well as other cell damage-associated proteins.
Conclusions:
The discovery and validation of stable, specific, sensitive and reproducible biomarkers of SCI is a rapidly expanding field of research. So far, few studies have utilised unbiased approaches aimed at the discovery of biomarkers within the CSF or blood in this field; however, some targeted approaches have been successfully used. Several studies using various animal models and some with small human patient cohorts have begun to pinpoint biomarkers in the CSF and blood with putative prognostic value. An increased sample size will be required to validate these biomarkers in the heterogeneous clinical setting.
Citation
Hulme, C., Brown, S., Fuller, H., Riddell, J., Osman, A., Chowdhury, J., …Wright, K. (2017). The Developing Landscape of Diagnostic and Prognostic Biomarkers for Spinal Cord Injury in Cerebrospinal Fluid and Blood. Spinal Cord, 55, 114-125. https://doi.org/10.1038/sc.2016.174
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 31, 2016 |
Online Publication Date | Dec 20, 2016 |
Publication Date | 2017-02 |
Journal | Spinal Cord |
Print ISSN | 1362-4393 |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 55 |
Pages | 114-125 |
DOI | https://doi.org/10.1038/sc.2016.174 |
Keywords | Spinal cord injury; biomarkers; prognostic; cerebrospinal fluid; blood; proteomics |
Publisher URL | http://dx.doi.org/10.1038/sc.2016.174 |
Files
8157_2_art_file_125732_cf117z.pdf
(301 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
437 CHARACTERISATION OF JUVENILE CARTILAGE TISSUES AND THEIR ISOLATED CHONDROCYTES FOR ALLOGENEIC CHONDROCYTE THERAPY
(2024)
Presentation / Conference
681 USING NANOPORE SEQUENCING TO DIAGNOSE PROSTHETIC JOINT INFECTIONS
(2024)
Presentation / Conference
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search